Netflix
NFLX
Disney
DIS
Qualcomm
QCOM
Meta Platforms
META
Cisco
CSCO
US Stock MarketDetailed Quotes
RCKT Rocket Pharmaceuticals
- 11.045
- +0.565+5.39%
Trading Jan 23 15:27 ET
1.15BMarket Cap-4.05P/E (TTM)
11.070High10.150Low777.12KVolume10.330Open10.480Pre Close8.27MTurnover0.93%Turnover RatioLossP/E (Static)104.36MShares31.47052wk High3.50P/B926.01MFloat Cap10.07052wk Low--Dividend TTM83.84MShs Float67.480Historical High--Div YieldTTM8.78%Amplitude7.565Historical Low10.647Avg Price1Lot Size
About Rocket Pharmaceuticals Company
Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. Its multi-platform development approach applies the lentiviral vector and adeno-associated viral vector gene therapy platforms. Its clinical program is an LVV-based gene therapy for the treatment of Fanconi Anemia (FA), a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer. The company was founded on July 7, 1999 and is headquartered in Cranbury, NJ.
Company Profile
SymbolRCKT
Company NameRocket Pharmaceuticals
Listing DateFeb 18, 2015
Issue Price6.00
Founded1999
CEODr. Gaurav Shah, M.D.
MarketNASDAQ
Employees268
Fiscal Year Ends12-31
Address9 Cedarbrook Drive
CityCranbury
ProvinceNew Jersey
CountryUnited States of America
Zip Code08512
Phone1-609-659-8001
Websitehttp://www.rocketpharma.com
Company Executives
- Name
- Position
- Salary
- Dr. Gaurav Shah, M.D.
- Director and Chief Executive Officer
- 8.01M
- Jonathan Schwartz, M.D.
- Chief Medical Officer and Chief Gene Therapy Officer
- 3.16M
- Aaron Ondrey
- Chief Financial Officer
- --
- Mayo Pujols
- Chief Technical Officer and Executive Vice President
- 4.38M
- Martin Wilson, J.D.
- Chief Corporate Officer, Senior Vice President, General Counsel and Chief Compliance Officer
- --
- Dr. Kinnari Patel, M.B.A.,Pharm.D.
- President, Chief Operating Officer and Head of R&D
- 4.85M
- Raj Prabhakar
- Chief Business Officer and Senior Vice President
- --
- John Militello, C.P.A.
- Vice President, Finance, Senior Controller, Treasurer and Principal Accounting Officer
- 1.53M
- Dr. Roderick Wong, M.D.
- Chairman of the Board
- 409.99K
- Dr. Mikael Dolsten, M.D.
- Director
- --
- Dr. Fady Ibraham Malik, M.D.,PhD
- Independent Director
- 399.99K
- Dr. Elisabeth Bjork, M.D.,PhD
- Independent Director
- 409.99K
- Robert Keith Woods
- Independent Director
- 568.70K
- Dr. Naveen Yalamanchi, M.D.
- Independent Director
- 417.49K
- Carsten Boess
- Independent Director
- 427.49K
- Dr. Gotham Makker, M.D.
- Independent Director
- 399.99K
- Pedro P. Granadillo
- Independent Director
- 429.98K
- David P. Southwell
- Independent Director
- 399.99K
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.